Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The current ratio is N/A as of Tuesday, October 6, 2026.
CURRENT RATIO
N/A
Thunder Bridge Capital Partners V L
Market Cap
$266.29M
Current Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.99M
Current Ratio
0.06
TTM Avg
1.58
3Y Avg
0.82
5Y Avg
0.82
Market Cap
$264.51M
Current Ratio
0.73
TTM Avg
1.67
3Y Avg
1.67
5Y Avg
1.67
Market Cap
$264.47M
Current Ratio
28.27
TTM Avg
10.31
3Y Avg
10.31
5Y Avg
10.31
Market Cap
$264.38M
Current Ratio
0.02
TTM Avg
3.15
3Y Avg
3.15
5Y Avg
3.15
Market Cap
$263.53M
Current Ratio
26.46
TTM Avg
0.05
3Y Avg
0.05
5Y Avg
0.05
Market Cap
$269.44M
Current Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thunder Bridge Capital Partners V L (TBCVU) | $266.29M | N/A | N/A | N/A | N/A |
| Hawthorn Bancshares, Inc. (HWBK)vs › | $265.68M | N/A | N/A | N/A | N/A |
| Translational Development Acquisition Corp. (TDAC)vs › | $266.99M | 0.06 | 1.58 | 0.82 | 0.82 |
| Oaktree Acquisition Corp. II (OACC)vs › | $264.51M | 0.73 | 1.67 | 1.67 | 1.67 |
| ProCap Acquisition Corp (PCAP)vs › | $264.47M | 28.27 | 10.31 | 10.31 | 10.31 |
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)vs › | $264.38M | 0.02 | 3.15 | 3.15 | 3.15 |
| Soren Acquisition Corp. (SORN)vs › | $263.53M | 26.46 | 0.05 | 0.05 | 0.05 |
| Kingstone Companies, Inc. (KINS)vs › | $269.34M | N/A | N/A | N/A | N/A |
| Runway Growth Finance Corp. (RWAY)vs › | $269.44M | N/A | N/A | N/A | N/A |
| Cartesian Growth Corp. Iv (CGCF)vs › | $270.05M | N/A | N/A | N/A | N/A |
Current Ratio
N/A
Quick Ratio
N/A
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
